Skip to main content
Premium Trial:

Request an Annual Quote

Stanford, Epinomics Collaborate on Cancer Immunotherapy Research

NEW YORK (GenomeWeb) – Stanford University's Park Institute for Cancer Immunotherapy and Epinomics announced they have agreed to collaborate on improving cancer immunotherapies by utilizing biomarkers and epigenomics technology.

Immunotherapy has been shown to be a promising approach for the effective treatment of cancer, including achieving long term remission in patients who have not responded to existing therapies, Epinomics Cofounder Paul Giresi said in a statement. However, he noted, there is no gold standard for the application or monitoring for this type of therapy.

Epinomics' goal is to use epigenomics technology and deep analytics to guide personalized medicine efforts. The company has developed technology to analyze the epigenome which it describes as the "software" that programs how our body functions.

"The key to unlocking the potential in immuno-oncology has been the development of a new technology for reading the epigenome and creation of a deep analytics framework that serves as a central intelligence hub for understanding immune function in human health and disease," Giresi said.

The Stanford team, led by Park Institute Director Crystal Mackall, plans to utilize biomarkers defined by Epinomics' immune intelligence framework to improve outcomes and reduce adverse events in immunotherapy clinical trials.

"I know we will benefit greatly from the expertise Epinomics has in the epigenomics field, including their analytics platform that is advancing therapeutic development efforts and discovery of biomarkers for use in clinical care for immuno-oncology applications," Mackall added.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.